| human | Q5 |
| P7893 | CIÊNCIAVITAE ID | DC18-39A7-F287 |
| P2798 | Loop ID | 30919 |
| P496 | ORCID iD | 0000-0002-4829-754X |
| P3829 | Publons author ID | 1294091 |
| P1053 | ResearcherID | M-3572-2013 |
| P1153 | Scopus author ID | 7202508239 |
| P166 | award received | Mulheres na Ciência | Q106043504 |
| P27 | country of citizenship | Portugal | Q45 |
| P69 | educated at | University of Lisbon | Q1122926 |
| Faculty of Pharmacy, University of Lisbon | Q10279482 | ||
| P108 | employer | Faculty of Pharmacy, University of Lisbon | Q10279482 |
| P734 | family name | Rodrigues | Q19540914 |
| Rodrigues | Q19540914 | ||
| Rodrigues | Q19540914 | ||
| P101 | field of work | pharmaceutical science | Q7180763 |
| P735 | given name | Cecilia | Q859234 |
| Cecilia | Q859234 | ||
| P106 | occupation | pharmacist | Q105186 |
| researcher | Q1650915 | ||
| P21 | sex or gender | female | Q6581072 |
| Q36129486 | (3'R)-hydroxytabernaelegantine C: A bisindole alkaloid with potent apoptosis inducing activity in colon (HCT116, SW620) and liver (HepG2) cancer cells. |
| Q60895765 | .DELTA.22-Ursodeoxycholic Acid, a Unique Metabolite of Administered Ursodeoxycholic Acid in Rats, Indicating Partial .beta.-Oxidation as a Major Pathway for Bile Acid Metabolism |
| Q35213848 | 6-Acetonyldihydrochelerythrine Is a Potent Inducer of Apoptosis in HCT116 and SW620 Colon Cancer Cells. |
| Q61805030 | A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation |
| Q43748609 | A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. |
| Q46483255 | A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid. |
| Q36293295 | Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation |
| Q91129956 | Ablation of RIP3 protects from dopaminergic neurodegeneration in experimental Parkinson's disease |
| Q52659705 | Acquired resistance to aromatase inhibitors: where we stand! |
| Q34619432 | Administration of tauroursodeoxycholic acid (TUDCA) reduces apoptosis following myocardial infarction in rat. |
| Q53984818 | Aging confers different sensitivity to the neurotoxic properties of unconjugated bilirubin. |
| Q57760176 | Amyloid β Peptide Compromises Neural Stem Cell Fate by Irreversibly Disturbing Mitochondrial Oxidative State and Blocking Mitochondrial Biogenesis and Dynamics |
| Q39144650 | Amyloid β peptides promote autophagy-dependent differentiation of mouse neural stem cells: Aβ-mediated neural differentiation. |
| Q48439902 | Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. |
| Q45908078 | Amyloid-β peptide-induced secretion of endoplasmic reticulum chaperone glycoprotein GRP94. |
| Q92662351 | Antitumour Potential of Gigartina pistillata Carrageenans against Colorectal Cancer Stem Cell-Enriched Tumourspheres |
| Q57760188 | Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis |
| Q54599587 | Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease. |
| Q43087408 | Apoptosis in transgenic mice expressing the P301L mutated form of human tau. |
| Q34705964 | Apoptosis inducing activity of benzophenanthridine-type alkaloids and 2-arylbenzofuran neolignans in HCT116 colon carcinoma cells. |
| Q33702714 | Apoptosis-associated microRNAs are modulated in mouse, rat and human neural differentiation |
| Q60632868 | Apoptotic cell death does not parallel other indicators of liver damage in chronic hepatitis C patients. |
| Q38694174 | Application of Tauroursodeoxycholic Acid for Treatment of Neurological and Non-neurological Diseases: Is There a Potential for Treating Traumatic Brain Injury? |
| Q89497403 | Association of Plasmodium berghei With the Apical Domain of Hepatocytes Is Necessary for the Parasite's Liver Stage Development |
| Q60895762 | Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei |
| Q28343505 | Bile acid patterns in meconium are influenced by cholestasis of pregnancy and not altered by ursodeoxycholic acid treatment |
| Q37064641 | Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease. |
| Q60895761 | Bile acids and hepatocyte apoptosis: Living/leaving life in the Fas lane |
| Q24653969 | Bile acids: regulation of apoptosis by ursodeoxycholic acid |
| Q43897796 | Bilirubin directly disrupts membrane lipid polarity and fluidity, protein order, and redox status in rat mitochondria. |
| Q30330240 | Bilirubin induces apoptosis via the mitochondrial pathway in developing rat brain neurons. |
| Q33181945 | Bilirubin-induced apoptosis in cultured rat neural cells is aggravated by chenodeoxycholic acid but prevented by ursodeoxycholic acid. |
| Q60895741 | Binding Studies of Bile Acids using the Native Fluorescence of the Tryptophan Residue Of Bax Protein |
| Q38695568 | Blue light potentiates neurogenesis induced by retinoic acid-loaded responsive nanoparticles |
| Q52727471 | Bovine oocyte membrane permeability and cryosurvival: Effects of different cryoprotectants and calcium in the vitrification media. |
| Q47881799 | Caspases and p53 modulate FOXO3A/Id1 signaling during mouse neural stem cell differentiation. |
| Q26749008 | Chemical Variations on the p53 Reactivation Theme |
| Q96681868 | Circulating Inflammatory miRNAs Associated with Parkinson's Disease Pathophysiology |
| Q41066462 | Clinical pharmacokinetics of therapeutic bile acids. |
| Q53144793 | Cobalt complexes bearing scorpionate ligands: synthesis, characterization, cytotoxicity and DNA cleavage. |
| Q45941821 | Colorectal cancer: can nutrients modulate NF-kappaB and apoptosis? |
| Q92514935 | Combining 1,3-Ditriazolylbenzene and Quinoline to Discover a New G-Quadruplex-Interactive Small Molecule Active against Cancer Stem-Like Cells |
| Q54588371 | Contrasting apoptotic responses of conjugated linoleic acid in the liver of obese Zucker rats fed palm oil or ovine fat. |
| Q48184314 | Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells. |
| Q92388521 | Copper complex nanoformulations featuring highly promising therapeutic potential in murine melanoma models |
| Q64092834 | Corrigendum: A Novel Small Molecule p53 Stabilizer for Brain Cell Differentiation |
| Q43557129 | Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype. |
| Q35617604 | Cyclopentadienyl-ruthenium(II) and iron(II) organometallic compounds with carbohydrate derivative ligands as good colorectal anticancer agents |
| Q50926535 | Cytotoxic bile acids, but not cytoprotective species, inhibit the ordering effect of cholesterol in model membranes at physiologically active concentrations. |
| Q91732484 | Deficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease |
| Q36197853 | Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties |
| Q91147887 | Development and Mechanistic Insight into the Enhanced Cytotoxic Potential of Parvifloron D Albumin Nanoparticles in EGFR-Overexpressing Pancreatic Cancer Cells |
| Q34048993 | Dibenzylbutane- and butyrolactone-type lignans as apoptosis inducers in human hepatoma HuH-7 cells. |
| Q57760185 | Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes |
| Q60895736 | Dinitro-o-cresol induces apoptosis-like cell death but not alternative oxidase expression in soybean cells |
| Q27676435 | Dissection of the network of interactions that links RNA processing with glycolysis in the Bacillus subtilis degradosome |
| Q35639780 | Distinct kinetics and pathways of apoptosis in influenza A and B virus infection. |
| Q38027806 | Endoplasmic reticulum enrollment in Alzheimer's disease. |
| Q30408769 | Essential versus accessory aspects of cell death: recommendations of the NCCD 2015. |
| Q99555837 | Evaluation of Tissue and Circulating miR-21 as Potential Biomarker of Response to Chemoradiotherapy in Rectal Cancer |
| Q111322494 | Exploring the Phytochemicals of Acacia melanoxylon R. Br |
| Q51750234 | Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis. |
| Q60895744 | Fooling the Fas ligand in death |
| Q57760186 | Function of nuclear steroid receptors in apoptosis: role of ursodeoxycholic acid |
| Q27663431 | Functional dissection of a trigger enzyme: mutations of the bacillus subtilis glutamate dehydrogenase RocG that affect differentially its catalytic activity and regulatory properties |
| Q48521410 | Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis. |
| Q22676705 | Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) |
| Q41764481 | Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. |
| Q125344445 | Harnessing Protein-Ligand Interaction Fingerprints to Predict New Scaffolds of RIPK1 Inhibitors |
| Q57760193 | Hepatocyte Apoptosis, Expression of Death Receptors, and Activation of NF-κB in the Liver of Nonalcoholic and Alcoholic Steatohepatitis Patients |
| Q104260361 | Host miRNA-21 promotes liver dysfunction by targeting small intestinal Lactobacillus in mice |
| Q113694971 | How to Treat Melanoma? The Current Status of Innovative Nanotechnological Strategies and the Role of Minimally Invasive Approaches like PTT and PDT |
| Q34212063 | Identification of microRNAs during rat liver regeneration after partial hepatectomy and modulation by ursodeoxycholic acid |
| Q91800741 | Imidazoline Receptor Agonists for Managing Hypertension May Hold Promise for Treatment of Intracerebral Hemorrhage |
| Q42209650 | Impaired cross-talk between the thioredoxin and glutathione systems is related to ASK-1 mediated apoptosis in neuronal cells exposed to mercury |
| Q57001330 | In Silico HCT116 Human Colon Cancer Cell-Based Models En Route to the Discovery of Lead-Like Anticancer Drugs |
| Q39838187 | Induction of apoptosis in HuH-7 cancer cells by monoterpene and beta-carboline indole alkaloids isolated from the leaves of Tabernaemontana elegans. |
| Q91414896 | Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease |
| Q39028760 | Insights into the mechanisms underlying the antiproliferative potential of a Co(II) coordination compound bearing 1,10-phenanthroline-5,6-dione: DNA and protein interaction studies |
| Q38695096 | In vitro targeting of colon cancer cells using spiropyrazoline oxindoles. |
| Q33873952 | Isoflavones as apoptosis inducers in human hepatoma HuH-7 cells. |
| Q60895707 | Isolation of Mitochondria from Liver and Extraction of Total RNA and Protein: Analyses of MicroRNA and Protein Expressions |
| Q35597456 | KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines. |
| Q95656627 | Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning? |
| Q34168368 | Liver and muscle in morbid obesity: the interplay of fatty liver and insulin resistance. |
| Q90734479 | Loss of Microglial Parkin Inhibits Necroptosis and Contributes to Neuroinflammation |
| Q61796855 | MEK5/ERK5 activation regulates colon cancer stem-like cell properties |
| Q41610131 | MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism |
| Q90260793 | Measuring the Impact of Bile Acids on the Membrane Order of Primary Hepatocytes and Isolated Mitochondria by Fluorescence Imaging and Spectroscopy |
| Q58763535 | Mechanism and disease implications of necroptosis and neuronal inflammation |
| Q44194736 | Membrane structural changes support the involvement of mitochondria in the bile salt-induced apoptosis of rat hepatocytes. |
| Q43226120 | Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis. |
| Q35008686 | MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. |
| Q53185606 | MicroRNA-145 Regulates Neural Stem Cell Differentiation Through the Sox2-Lin28/let-7 Signaling Pathway. |
| Q48690916 | MicroRNA-34a Modulates Neural Stem Cell Differentiation by Regulating Expression of Synaptic and Autophagic Proteins. |
| Q38463278 | Mitochondria: Major Regulators of Neural Development |
| Q33836633 | Mitochondrial membrane perturbations in cholestasis. |
| Q34009243 | Mitochondrial translocation of p53 modulates neuronal fate by preventing differentiation-induced mitochondrial stress |
| Q42905339 | Modulation of amyloid-β peptide-induced toxicity through inhibition of JNK nuclear localization and caspase-2 activation. |
| Q36638671 | Modulation of hepatocyte apoptosis: cross-talk between bile acids and nuclear steroid receptors. |
| Q44955749 | Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-beta1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes. |
| Q43575682 | Modulation of steady-state messenger RNA levels in the regenerating rat liver with bile acid feeding. |
| Q27676512 | Molecular Basis of the Activity of SinR Protein, the Master Regulator of Biofilm Formation in Bacillus subtilis |
| Q47843948 | Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. |
| Q126112258 | Monocarbonyl Analogs of Curcumin with Potential to Treat Colorectal Cancer |
| Q34842722 | Monoterpene bisindole alkaloids, from the African medicinal plant Tabernaemontana elegans, induce apoptosis in HCT116 human colon carcinoma cells. |
| Q35689856 | Monoterpene indole alkaloid hydrazone derivatives with apoptosis inducing activity in human HCT116 colon and HepG2 liver carcinoma cells. |
| Q50438231 | N-acetylcysteine treatment attenuates the cognitive impairment and synaptic plasticity loss induced by streptozotocin. |
| Q60895737 | NF-?B and apoptosis in colorectal tumourigenesis |
| Q51656629 | Nanoformulations of a potent copper-based aquaporin inhibitor with cytotoxic effect against cancer cells. |
| Q45982367 | Naphtho[2,3-d]isoxazole-4,9-dione-3-carboxylates: potent, non-cytotoxic, antiapoptotic agents. |
| Q90260806 | Necrosome Formation and Necroptosis in Experimental Cholestasis |
| Q43937496 | Neuroprotection by a bile acid in an acute stroke model in the rat. |
| Q92991016 | New Lectins from Mediterranean Flora. Activity against HT29 Colon Cancer Cells |
| Q53095820 | New [(η(5)-C5H5)Ru(N-N)(PPh3)][PF6] compounds: colon anticancer activity and GLUT-mediated cellular uptake of carbohydrate-appended complexes. |
| Q28568025 | Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-beta1-induced apoptosis in rat hepatocytes |
| Q89984858 | Phenotypic high-throughput screening platform identifies novel chemotypes for necroptosis inhibition |
| Q57760191 | Plasma levels of ursodeoxycholic acid in black bears, Ursus americanus: Seasonal changes |
| Q34477590 | Prevention of acute kidney injury by tauroursodeoxycholic acid in rat and cell culture models. |
| Q91335500 | Processes exacerbating apoptosis in non-alcoholic steatohepatitis |
| Q57746323 | Progesterone and Caspase-3 Activation in Equine Cyclic Corpora Lutea |
| Q104572392 | RIPK3 acts as a lipid metabolism regulator contributing to inflammation and carcinogenesis in non-alcoholic fatty liver disease |
| Q28488964 | RNase Y in Bacillus subtilis: a Natively disordered protein that is the functional equivalent of RNase E from Escherichia coli |
| Q52807234 | Relevance of serum bile acid profile in the diagnosis of intrahepatic cholestasis of pregnancy in an high incidence area: Portugal. |
| Q38202220 | Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease. |
| Q37595591 | Role of nuclear steroid receptors in apoptosis. |
| Q43236433 | Safety, tolerability, and cerebrospinal fluid penetration of ursodeoxycholic Acid in patients with amyotrophic lateral sclerosis. |
| Q92569012 | Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance |
| Q49506881 | Spirotriazoline oxindoles: A novel chemical scaffold with in vitro anticancer properties |
| Q46569216 | Synthesis and evaluation of spiroisoxazoline oxindoles as anticancer agents |
| Q30620946 | Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid. |
| Q39107877 | Synthesis, G-quadruplex stabilisation, docking studies, and effect on cancer cells of indolo[3,2-b]quinolines with one, two, or three basic side chains. |
| Q48603223 | TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice. |
| Q35646234 | Targeting KRAS Oncogene in Colon Cancer Cells with 7-Carboxylate Indolo[3,2-b]quinoline Tri-Alkylamine Derivatives. |
| Q60895713 | Targeting miR-506 in primary biliary cirrhosis to support the HCO3− umbrella |
| Q37760528 | Targeting the p53 pathway of apoptosis. |
| Q60895763 | Tauroursodeoxycholate increases rat liver ursodeoxycholate levels and limits lithocholate formation better than ursodeoxycholate |
| Q38769589 | Tauroursodeoxycholic Acid Enhances Mitochondrial Biogenesis, Neural Stem Cell Pool, and Early Neurogenesis in Adult Rats |
| Q40241292 | Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells. |
| Q37384925 | Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells. |
| Q46518646 | Tauroursodeoxycholic acid protects retinal neural cells from cell death induced by prolonged exposure to elevated glucose |
| Q35022852 | Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats |
| Q48496803 | Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice. |
| Q34075502 | Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. |
| Q55448142 | The Emerging Role of microRNAs in Aquaporin Regulation. |
| Q38870068 | The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target |
| Q27680466 | The YmdB Phosphodiesterase Is a Global Regulator of Late Adaptive Responses in Bacillus subtilis |
| Q50044692 | The analytical challenge in the determination of cathinones, key-players in the worldwide phenomenon of novel psychoactive substances. |
| Q44931390 | The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. |
| Q50052495 | The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease |
| Q55519853 | The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma. |
| Q53781319 | The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation. |
| Q60632870 | Unusual case of severe cholestasis of pregnancy with early onset, improved by ursodeoxycholic acid administration |
| Q27673140 | Unusual, dual endo- and exonuclease activity in the degradosome explained by crystal structure analysis of RNase J1 |
| Q42921163 | Ursodeoxycholic acid modulates the ubiquitin-proteasome degradation pathway of p53. |
| Q28373562 | Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation |
| Q38602520 | Ursodeoxycholic acid: effects on hepatic unfolded protein response, apoptosis and oxidative stress in morbidly obese patients. |
| Q36153425 | Vobasinyl-Iboga Alkaloids from Tabernaemontana elegans: Cell Cycle Arrest and Apoptosis-Inducing Activity in HCT116 Colon Cancer Cells. |
| Q60895712 | c-Jun Regulates the Stability of Anti-Apoptotic ΔNp63 in Amyloid-β-Induced Apoptosis |
| Q36962611 | miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells. |
| Q60895711 | miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease |
| Q90954637 | miRNAs as Modulators of EGFR Therapy in Colorectal Cancer |
| Q46624539 | microRNAs in Mitochondria: An Unexplored Niche. |
| Q49999392 | microRevolution in understanding primary biliary cholangitis pathophysiology |
| Q37613275 | p53 and the regulation of hepatocyte apoptosis: implications for disease pathogenesis. |
| Q47990587 | p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells. |
| Q33869591 | p53 interaction with JMJD3 results in its nuclear distribution during mouse neural stem cell differentiation. |
| Q28568391 | p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis |
Search more.